The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Development, roll-out and impact of Xpert MTB/RIF for tuberculosis: what lessons have we learnt and how can we do better?
Open accessAbstract
The global roll-out of Xpert MTB/RIF (Cepheid Inc., Sunnyvale, CA, USA) has changed the diagnostic landscape of tuberculosis (TB). More than 16 million tests have been performed in 122 countries since 2011, and detection of multidrug-resistant TB has increased three- to eight-fold compared to conventional testing. The roll-out has galvanised stakeholders, from donors to civil society, and paved the way for universal drug susceptibility testing. It has attracted new product developers to TB, resulting in a robust molecular diagnostics pipeline. However, the roll-out has also highlighted gaps that have constrained scale-up and limited impact on patient outcomes. The roll-out has been hampered by high costs for under-funded programmes, unavailability of a complete solution package (notably comprehensive training, quality assurance, implementation plans, inadequate service and maintenance support) and lack of impact assessment. Insufficient focus has been afforded to effective linkage to care of diagnosed patients, and clinical impact has been blunted by weak health systems. In many countries the private sector plays a dominant role in TB control, yet this sector has limited access to subsidised pricing. In light of these lessons, we advocate for a comprehensive diagnostics implementation approach, including increased engagement of in-country stakeholders for product launch and roll-out, broader systems strengthening in preparation for new technologies, as well as quality impact data from programmatic settings.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Rapid Molecular Detection of Tuberculosis and Rifampin Resistance
Boehme, C. C., Nabeta, P., Hillemann, D., Nicol, M. P., Shenai, S., Krapp, F., Allen, J., Tahirli, R., Blakemore, R., Rustomjee, R., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0907847 · Cited by 2,309
Self-citationBoehme, C. C., Nicol, M. P., Nabeta, P., Michael, J. S., Gotuzzo, E., Tahirli, R., Gler, M. T., Blakemore, R., Worodria, W., Gray, C., et al. (2011) · The Lancet · doi:10.1016/s0140-6736(11)60438-8 · Cited by 1,013
Self-citationTheron, G., Zijenah, L., Chanda, D., Clowes, P., Rachow, A., Lesosky, M., Bara, W., Mungofa, S., Pai, M., Hoelscher, M., et al. (2014) · The Lancet · doi:10.1016/s0140-6736(13)62073-5 · Cited by 433
Self-citationVassall, A., van Kampen, S., Sohn, H., Michael, J. S., John, K. R., den Boon, S., Davis, J. L., Whitelaw, A., Nicol, M. P., Gler, M. T., et al. (2011) · PLoS Medicine · doi:10.1371/journal.pmed.1001120 · Cited by 313
Self-citationRapid molecular TB diagnosis: evidence, policy making and global implementation of Xpert MTB/RIF
Weyer, K., Mirzayev, F., Migliori, G. B., Van Gemert, W., D'Ambrosio, L., Zignol, M., Floyd, K., Centis, R., Cirillo, D. M., Tortoli, E., et al. (2013) · European Respiratory Journal · doi:10.1183/09031936.00157212 · Cited by 256
Use of standardised patients to assess quality of tuberculosis care: a pilot, cross-sectional study
Das, J., Kwan, A., Daniels, B., Satyanarayana, S., Subbaraman, R., Bergkvist, S., Das, R. K., Das, V., & Pai, M. (2015) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(15)00077-8 · Cited by 237
Self-citationChurchyard, G. J., Stevens, W. S., Mametja, L. D., McCarthy, K. M., Chihota, V., Nicol, M. P., Erasmus, L. K., Ndjeka, N. O., Mvusi, L., Vassall, A., et al. (2015) · The Lancet Global Health · doi:10.1016/s2214-109x(15)00100-x · Cited by 209
Results from early programmatic implementation of Xpert MTB/RIF testing in nine countries
Creswell, J., Codlin, A. J., Andre, E., Micek, M. A., Bedru, A., Carter, E. J., Yadav, R.-P., Mosneaga, A., Rai, B., Banu, S., et al. (2014) · BMC Infectious Diseases · doi:10.1186/1471-2334-14-2 · Cited by 175
Defining the Needs for Next Generation Assays for Tuberculosis
Denkinger, C. M., Kik, S. V., Cirillo, D. M., Casenghi, M., Shinnick, T., Weyer, K., Gilpin, C., Boehme, C. C., Schito, M., Kimerling, M., et al. (2015) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiu821 · Cited by 167
Self-citationCox, H. S., Mbhele, S., Mohess, N., Whitelaw, A. C., Muller, O., Zemanay, W., Little, F., Azevedo, V. D., Simpson, J. A., Boehme, C. C., et al. (2014) · PLoS Medicine · doi:10.1371/journal.pmed.1001760 · Cited by 153
Self-citation
Cited by
Pai, M., Behr, M. A., Dowdy, D., Dheda, K., Divangahi, M., Boehme, C. C., Ginsberg, A., Swaminathan, S., Spigelman, M., Getahun, H., et al. (2016) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2016.76 · Cited by 1,270
Self-citationFurin, J., Cox, H., & Pai, M. (2019) · The Lancet · doi:10.1016/s0140-6736(19)30308-3 · Cited by 873
Self-citationStemming the Superbug Tide: Just A Few Dollars More
OECD (2018) · OECD Health Policy Studies · doi:10.1787/9789264307599-en · Cited by 748
Chakravorty, S., Simmons, A. M., Rowneki, M., Parmar, H., Cao, Y., Ryan, J., Banada, P. P., Deshpande, S., Shenai, S., Gall, A., et al. (2017) · mBio · doi:10.1128/mbio.00812-17 · Cited by 668
Self-citationKyu, H. H., Maddison, E. R., Henry, N. J., Ledesma, J. R., Wiens, K. E., Reiner, R., Biehl, M. H., Shields, C., Osgood-Zimmerman, A., Ross, J. M., et al. (2018) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(18)30625-x · Cited by 437
Qin, Z. Z., Sander, M. S., Rai, B., Titahong, C. N., Sudrungrot, S., Laah, S. N., Adhikari, L. M., Carter, E. J., Puri, L., Codlin, A. J., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-51503-3 · Cited by 289
India’s syndemic of tuberculosis and COVID-19
Shrinivasan, R., Rane, S., & Pai, M. (2020) · BMJ Global Health · doi:10.1136/bmjgh-2020-003979 · Cited by 71
Self-citationRahman, M. T., Codlin, A. J., Rahman, M. M., Nahar, A., Reja, M., Islam, T., Qin, Z. Z., Khan, M. A. S., Banu, S., & Creswell, J. (2017) · European Respiratory Journal · doi:10.1183/13993003.02159-2016 · Cited by 66
Saavedra, B., Mambuque, E., Nguenha, D., Gomes, N., Munguambe, S., García, J. I., Izco, S., Acacio, S., Murias-Closas, A., Cossa, M., et al. (2021) · European Respiratory Journal · doi:10.1183/13993003.00257-2021 · Cited by 25
Auld, A. F., Agizew, T., Mathoma, A., Boyd, R., Date, A., Pals, S. L., Serumola, C., Mathebula, U., Alexander, H., Ellerbrock, T. V., et al. (2020) · BMC Medicine · doi:10.1186/s12916-019-1489-0 · Cited by 14
Metadata
- Authors
- Albert, H., Nathavitharana, R. R., Isaacs, C., Pai, M., Denkinger, C. M., & Boehme, C. C.
- Venue
- European Respiratory Journal
- Publisher
- European Respiratory Society (ERS)
- Published
- 2016-07-13
- Volume
- 48
- Issue
- 2
- Pages
- 516-525
- ISSN
- 0903-1936 (ISSN-L)
- 1399-3003
- OpenAlex
- W2472138188
- Cited by
- 300
- References
- 32
- FWCI
- 38.09
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.